^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    alpha-lactalbumin vaccine

    i
    Associations
    News

    Trials

    Company:
    Anixa Biosci, Cleveland Clinic
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Adjuvant Therapy with an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer (CASE6119) (NCT04674306)
    Phase 1
    George T. Budd
    Recruiting
    Last update posted :
    02/12/2025
    Initiation :
    10/01/2021
    Primary completion :
    05/01/2025
    Completion :
    11/01/2025
    HER-2 • ER • PGR • BRCA1 • PRL
    |
    HER-2 negative • PALB2 mutation • ER negative
    |
    alpha-lactalbumin vaccine